Latoya's Migraine Story
Latoya: I wanted my children to look back and say, 'mommy was there.'
Super: QULIPTA® (atogepant) is a prescription medicine used for the preventive treatment of migraine in adults. Keep watching for Important Safety Information.
Latoya: With QULIPTA, I found something that works really well for me.
Text on screen: Latoya's Migraine Story
Super: Latoya is an actual QULIPTA patient who was on prescribed therapy when she provided this testimonial. Changes in therapy status may have occurred since that time. Latoya was compensated for sharing her story.
Latoya: I don't think I realized how much migraine centered my world and made it so confined. I had a lot of mom guilt. I have three wonderful boys and mommy couldn't play all the time.
Super: IMPORTANT SAFETY INFORMATION. Do not take QULIPTA® if you have had an allergic reaction to atogepant or any ingredients in QULIPTA.
Latoya: Something just had to change. I couldn't continue living the way I was living. It's very important to advocate for yourself. To be able to say, there's something wrong, something needs to be done, please fix it. You don't have to struggle for years. I tried several different migraine prescriptions, but they just weren't for me. Some were not specifically for migraine and have other uses. QULIPTA is specifically for migraine.
Super: QULIPTA® (atogepant) is a prescription medicine used for the preventive treatment of migraine in adults
Latoya: When I decided to try QULIPTA, my treatment goals were to reduce my monthly migraine attacks.
Super: In 3-month studies, QULIPTA® helped significantly reduce monthly migraine days. Individual results may vary.
Latoya: QULIPTA works really well for me. It reduces the amount of migraine attacks that I get. Whenever I tell anyone about QULIPTA, I tell them my life is less impacted by migraine. I have not canceled plans lately. I'm showing up. Latoya's in the building.
Text on Screen: TALK TO YOUR DOCTOR ABOUT A MIGRAINE-SPECIFIC MEDICATION
IMPORTANT SAFETY INFORMATION
Do not take QULIPTA® if you have had an allergic reaction to atogepant or any ingredients in QULIPTA.
Before taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you:
- Have high blood pressure
- Have circulation problems in your fingers and toes
- Have kidney problems or are on dialysis
- Have liver problems
- Are pregnant or plan to become pregnant
- Are breastfeeding or plan to breastfeed
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. QULIPTA may affect the way other medicines work, and other medicines may affect how QULIPTA works. Your healthcare provider may need to change the dose of QULIPTA when taken with certain other medicines.
QULIPTA can cause serious side effects, including:
- Allergic (hypersensitivity) reactions, including anaphylaxis: Serious allergic reactions can happen when you take QULIPTA or days after. Stop taking QULIPTA and get emergency medical help right away if you get any of the following symptoms, which may be part of a serious allergic reaction: swelling of the face, lips, or tongue; itching; trouble breathing; hives; or rash.
- High blood pressure: New or worsening of high blood pressure can happen. Contact your healthcare provider if you have an increase in blood pressure.
- Raynaud's phenomenon: A type of circulation problem can worsen or happen. Raynaud's phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur.
The most common side effects of QULIPTA are nausea, constipation, and fatigue/sleepiness. These are not all the possible side effects of QULIPTA.
QULIPTA is available in 10 mg, 30 mg, and 60 mg tablets.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.
Please see Patient Information at QULIPTA.com, or visit Rxabbvie.com/pdf/QULIPTA_pil.pdf
©2025 AbbVie. All right reserved. US-QLP-240270